🇺🇸 FDA
Patent

US 8486923

Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

granted A61KA61K31/58A61K45/06

Quick answer

US patent 8486923 (Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis) held by TAKEDA GMBH expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TAKEDA GMBH
Grant date
Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/58, A61K45/06, A61K9/0043, A61P